Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kevin Pantalone DO, ECNU, CCD

Kevin M. Pantalone DO, ECNU, CCD

Staff Endocrinologist and Director of Diabetes Initiatives, Department of Endocrinology, Cleveland Clinic, Cleveland, Ohio

Dr. Pantalone is a board certified Staff Endocrinologist at Cleveland Clinic in Cleveland, Ohio. Dr. Pantalone also completed his internal medicine residency and endocrinology fellowship at Cleveland Clinic. His clinical focus is on the glycemic management of type 2 diabetes, as well as the diagnosis and management of low testosterone in men, thyroid disorders, and pituitary tumors. His research interests are related to the adverse effects of diabetes therapies, particularly those related to sulfonylureas.


Dr. Pantalone reports grants and personal fees from Bayer, personal fees from AstraZeneca, personal fees from Sanofi, personal fees from Corcept Therapeutics, personal fees from Eli Lilly, grants and personal fees from Novo Nordisk, grants and personal fees from Merck & Co, personal fees from Diasome, and grants from Twinhealth, outside the submitted work.